Biogen Inc. buy Needham & Company LLC
Start price
25.07.23
/
50%
€242.80
Target price
25.07.24
€290.08
Performance (%)
-13.55%
End price
26.07.24
€209.90
Summary
This prediction ended on 26.07.24 with a price of €209.90. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.55%. Needham___Company_LL has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 8.456% | 8.456% | 76.007% |
| iShares Core DAX® | -1,43 % | -1,43 % | 2,28 % |
| iShares Nasdaq 100 | -1,98 % | 0,17 % | 35,59 % |
| iShares Nikkei 225® | -3,85 % | 6,53 % | 59,08 % |
| iShares S&P 500 | -0,47 % | 0,24 % | 24,69 % |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $320.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten